Literature DB >> 22183064

Systemic hypertension: the roles of salt, vascular Na+/K+ ATPase and the endogenous glycosides, ouabain and marinobufagenin.

Christopher Hauck1, William H Frishman.   

Abstract

Essential hypertension has been shown to be significantly associated with an increased risk for cardiovascular disease and is not well controlled in many patients. In a large portion of people with essential hypertension, sodium intake has been shown to play a significant role in the production of their hypertension. The mechanism through which increased sodium intake manifests hypertension is unresolved and likely multifactorial. Endogenous cardiac glycosides such as endogenous ouabain (EO) and marinobufagenin have been proposed to play a role in salt-sensitive essential hypertension through their inhibition of Na/K ATPase (NKA). The normal function of the NKA pump is to extrude Na from the intracellular environment and import K. Blocking the NKA disrupts its normal maintenance function. EO is proposed to produce alteration in smooth muscle cell contractility by inhibiting the α2-isoform of NKA, altering Na in a microdomain of the cell. In this region of the plasma membrane the α2-isoform of the NKA colocalizes with another transmembrane protein, the Na/Ca exchanger (NCX). The normal function of NCX is to extrude Ca and import Na. Inhibition of NKA produces an increase in Na within the microdomain, which in turn alters the function of the NCX so that less Ca is extruded, leading to increased intracellular Ca and increased vascular contraction. EO has been shown to be synthesized and secreted by the adrenal cortex in response to chronically elevated sodium intake. The levels of EO have been shown to be significantly elevated in 40% of all untreated hypertensive patients. Marinobufagenin, another cardiac glycoside, has also been implicated as a possible cause of essential hypertension through its preferential inhibition of the α1-isoform of NKA. Antagonism of the endogenous inhibitors of NKA is currently a target of clinical research for the development of innovative antihypertensive treatments.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22183064     DOI: 10.1097/CRD.0b013e31823c835c

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  17 in total

Review 1.  Novel role of ouabain as a cystogenic factor in autosomal dominant polycystic kidney disease.

Authors:  Gustavo Blanco; Darren P Wallace
Journal:  Am J Physiol Renal Physiol       Date:  2013-06-12

2.  Computational modeling of anoctamin 1 calcium-activated chloride channels as pacemaker channels in interstitial cells of Cajal.

Authors:  Rachel Lees-Green; Simon J Gibbons; Gianrico Farrugia; James Sneyd; Leo K Cheng
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-01-30       Impact factor: 4.052

Review 3.  Salt-Sensitive Hypertension: Perspectives on Intrarenal Mechanisms.

Authors:  Dewan S A Majid; Minolfa C Prieto; Luis Gabriel Navar
Journal:  Curr Hypertens Rev       Date:  2015

4.  Increased constrictor tone induced by ouabain treatment in rats.

Authors:  Victor M Pulgar; Anne B Jeffers; Hanadi M Rashad; Debra I Diz; Azeez A Aileru
Journal:  J Cardiovasc Pharmacol       Date:  2013-08       Impact factor: 3.105

5.  Probing the regiospecificity of enzyme-catalyzed steroid glycosylation.

Authors:  Maoquan Zhou; Yanpeng Hou; Adel Hamza; Christophe Pain; Chang-Guo Zhan; Tim S Bugni; Jon S Thorson
Journal:  Org Lett       Date:  2012-10-18       Impact factor: 6.005

6.  The Effects of Short-Term Changes in Sodium Intake on Plasma Marinobufagenin Levels in Patients with Primary Salt-Sensitive and Salt-Insensitive Hypertension.

Authors:  Katarzyna Łabno-Kirszniok; Agata Kujawa-Szewieczek; Andrzej Wiecek; Grzegorz Piecha
Journal:  Nutrients       Date:  2021-04-29       Impact factor: 5.717

Review 7.  Much More than a Cardiotonic Steroid: Modulation of Inflammation by Ouabain.

Authors:  Luiz H A Cavalcante-Silva; Éssia de Almeida Lima; Deyse C M Carvalho; José M de Sales-Neto; Anne K de Abreu Alves; José G F M Galvão; Juliane S de França da Silva; Sandra Rodrigues-Mascarenhas
Journal:  Front Physiol       Date:  2017-11-10       Impact factor: 4.566

8.  Neglect of several important indexes during the study of human essential hypertension.

Authors:  Zuoguang Wang; Xiaoyun Peng; Yongxiang Wei; Shaojun Wen
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-07-01       Impact factor: 3.738

9.  Effect of urinary angiotensinogen and high-salt diet on blood pressure in patients with chronic kidney disease: results from the Korean Cohort Study for Outcome in Patients with Chronic Kidney Disease (KNOW-CKD).

Authors:  Ha Yeon Kim; Hong Sang Choi; Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Su-Ah Sung; Seung Hyeok Han; Kook-Hwan Oh; Curie Ahn; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2020-10-08       Impact factor: 2.884

Review 10.  Endogenous digitalis-like factors: an overview of the history.

Authors:  Vardaman M Buckalew
Journal:  Front Endocrinol (Lausanne)       Date:  2015-04-13       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.